ArticleStem cell research & therapy2025

Intratracheal administration of mesenchymal stem cells ameliorates hyperoxia-induced bronchopulmonary dysplasia by inhibiting NLRP3 inflammasome activation: the critical role of Aldh1a2.

Xuejing Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.